|
|
|
 |
FDA Approval Activities for this Drug…
Hectorol (Doxercalciferol) Capsules, 2.5 mcg, Bone Care International NDA 20-862 6/9/99 6/11/99 6/11/99 6/29/00 | Hectorol Indication:For the reduction of elevated iPTH levels in the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis. | Hectorol IV, Bone Care International NDA 21-027 Hectorol (doxercalciferol) Injection, Bone Care International | Hectorol (Doxercalciferol) Capsules, Bone Care International | Hectorol (doxercalciferol) Capsules, Bone Care Intl., Labeling Revision | Hectorol (doxercalciferol) Injection, Bone Care Intl., Labeling Revision | Hectorol (doxercalciferol) Capsules, Bone Care Intl., Labeling Revision | Hectorol (doxercalciferol) Capsules, Genzyme Corp., Labeling Revision | Hectorol (doxercalciferol) Injection, Genzyme Corp., Labeling Revision | Hectorol (doxercalciferol) Capsules, Genzyme Corp., Control Supplement | Hectorol (doxercalciferol) Injection, Genzyme, Formulation Revision | Hectorol (doxercalciferol) Injection, Genzyme Corporation, Formulation Revision | Hectorol (doxercalciferol) Capsules, Genzyme Corp., Control Supplement | Doxercalciferol Injection, Mylan Pharmaceuticals, Inc., Tentative Approval | Hectorol (doxercalciferol) Capsules, Genzyme Corp., Labeling Revision | Hectorol (doxercalciferol) Capsules, Genzyme Corporation, Labeling Revision | Doxercalciferol Injection, Cobrek Pharmaceuticals, Inc., Tentative Approval | Doxercalciferol Injection, Cobrek Pharmaceuticals, Inc., Tentative Approval | Doxercalciferol Injection, Sandoz Inc., Tentative Approval | Doxercalciferol Injection, Mylan Institutional, LLC, Tentative Approval | Doxercalciferol Capsules, Roxane Laboratories, Inc., Approval
  
|